Newly Engineered Versions of Bacterial Enzyme Reveal How Antibiotics Could Be More Potent
Retrieved on:
Wednesday, August 30, 2023
Pseudomonadota, Bacillota, DNA, Nature, Multiplex, Infection, NYU, New York University Grossman School of Medicine, National Institutes of Health, Howard Hughes Medical Institute, Escherichia coli, Research, Cell, RNA, Doctor of Philosophy, Dicarboxylic acid, MAGE, NYU Langone Health, Protein, Pyrimidine, MD, Growth, Bacteria, Gene, RNAP, Medicine, Antibiotics, Vaccine, Biochemistry
NEW YORK, Aug. 30, 2023 /PRNewswire/ -- Modern medicine depends on antibiotics to treat infections by disabling targets inside bacterial cells.
Key Points:
- NEW YORK, Aug. 30, 2023 /PRNewswire/ -- Modern medicine depends on antibiotics to treat infections by disabling targets inside bacterial cells.
- Once inside these cells, antibiotics bind to certain sites on specific enzyme targets to stop bacterial growth.
- Researchers have for decades studied resistant mutants in hopes that related mechanisms would guide the design of new treatments to overcome resistance.
- Not only does the antibiotic prevent these mutants from growing, it nearly obliterates the mutant bacterial populations.